A Randomized, Open-Label, Comparative, Parallel-Group, Multicenter Study of SPARC1507

Summary

An open label study to determine the efficacy and safety of SPARC1507

Timeline

Start

2018-12-01

Primary completion

2019-03-01

Completion

2019-12-01

Outcome

Outcome not reported

Stopped (Business): “Sponsor decided not to initiate the study for alternate commercial strategy”

Drugs

Indications